On March 2, 2013, the American Academy of Dermatology Association’s (AADA's) Board of Directors unanimously approved a new position statement on pathology billing. The position statement is intended to educate AADA members about the appropriateness of and risks associated with performing and/or billing for dermatopathology services.
Whether and how the new statement applies to you will depend on how your individual practice provides, purchases, and bills for dermatopathology services, as well as applicable state and federal laws and individual payer policies. The information below addresses some specific questions arising from the new position statement. This information is provided for educational purposes only and is not intended to be, and should not be, relied upon as legal advice.